TY - JOUR
T1 - Membrane-bound or soluble truncated RT1.Aa rat class I major histocompatibility antigens induce specific alloimmunity
AU - Ghobrial, Rafik
AU - Hamashima, Takashi
AU - Kloc, Malgorzata
AU - Etkin, Laurence
AU - Stepkowski, Stanislaw M.
AU - Kahan, Barry D.
PY - 1995/9
Y1 - 1995/9
N2 - Transfectants that express membrane-bound (MB) or secrete soluble truncated (TR) rat class I RT1.Aa major histocompatibility (MHC) antigens induce alloimmunity in vivo. The MB-RT1.Aa was produced by transfecting the full-length RT1.Aa cDNA, including the α1, α2, and α3, transmembrane and intracellular domains. The TR-RT1.Aa cDNA insert included only the extracellular α1, α2, and α3 domains; a stop codon was placed in front of the transmembrane domain. Following full-length sequencing, MB-RT1.Aa and TR-RT1.Aa cDNAs were translated in vitro into glycosylated MB-RT1.Aa (45 kDa) and TR-RT1.Aa (36 kDa) proteins, respectively. Each cDNA construct was individually subcloned into the pSG5 vector before transfection into Buffalo (BUF; RT1b) hepatoma cells. FACscan analysis with anti-RT1.Aa-specific R2/15S monoclonal antibody (MAb) confirmed surface expression of RT1.Aa molecules on the MB-RT1.Aa, but not on the TR-RT1.Aa, transfectants. In contrast, enzyme-linked immunoadsorbent assays documented the presence of soluble RT1.Aa molecules in supernates from cells transfected with the TR- RT1.Aa, but not from cells transfected with the MB-RT1.Aa, cDNA. Subcutaneous injection of MB-RT1.Aa or TR-RT1.Aa transfectants to BUF or Wistar Furth (WF; RT1(u)) rats induced accelerated rejection of ACI (RT1a) but not third-party Brown Norway (RT1(n)) heart allografts. Furthermore, supernates of TR-RT1.Aa, but not of MB-RT1.Aa, transfectants immunized WF hosts toward ACI hearts. Thus, both intact MB-RT1.Aa and soluble TR-RT1.Aa class I alloantigensinduce potent sensitization against alloantigens.
AB - Transfectants that express membrane-bound (MB) or secrete soluble truncated (TR) rat class I RT1.Aa major histocompatibility (MHC) antigens induce alloimmunity in vivo. The MB-RT1.Aa was produced by transfecting the full-length RT1.Aa cDNA, including the α1, α2, and α3, transmembrane and intracellular domains. The TR-RT1.Aa cDNA insert included only the extracellular α1, α2, and α3 domains; a stop codon was placed in front of the transmembrane domain. Following full-length sequencing, MB-RT1.Aa and TR-RT1.Aa cDNAs were translated in vitro into glycosylated MB-RT1.Aa (45 kDa) and TR-RT1.Aa (36 kDa) proteins, respectively. Each cDNA construct was individually subcloned into the pSG5 vector before transfection into Buffalo (BUF; RT1b) hepatoma cells. FACscan analysis with anti-RT1.Aa-specific R2/15S monoclonal antibody (MAb) confirmed surface expression of RT1.Aa molecules on the MB-RT1.Aa, but not on the TR-RT1.Aa, transfectants. In contrast, enzyme-linked immunoadsorbent assays documented the presence of soluble RT1.Aa molecules in supernates from cells transfected with the TR- RT1.Aa, but not from cells transfected with the MB-RT1.Aa, cDNA. Subcutaneous injection of MB-RT1.Aa or TR-RT1.Aa transfectants to BUF or Wistar Furth (WF; RT1(u)) rats induced accelerated rejection of ACI (RT1a) but not third-party Brown Norway (RT1(n)) heart allografts. Furthermore, supernates of TR-RT1.Aa, but not of MB-RT1.Aa, transfectants immunized WF hosts toward ACI hearts. Thus, both intact MB-RT1.Aa and soluble TR-RT1.Aa class I alloantigensinduce potent sensitization against alloantigens.
UR - http://www.scopus.com/inward/record.url?scp=0029145646&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029145646&partnerID=8YFLogxK
U2 - 10.1097/00007890-199509270-00014
DO - 10.1097/00007890-199509270-00014
M3 - Article
C2 - 7570958
AN - SCOPUS:0029145646
SN - 0041-1337
VL - 60
SP - 602
EP - 610
JO - Transplantation
JF - Transplantation
IS - 6
ER -